George Medicines
Pharmaceutical Manufacturing • 
London, England, United Kingdom • 1-10 Employees
Company overview
| Headquarters | 9 Dallington Street, London, England EC1V 0BZ, GB |
| Phone number | +447983578290 |
| Website | |
| NAICS | 3254 |
| Keywords | Public Health, Global Health, Medical Research, Heart Disease, Commercialisation Of Healthcare Technology, Late Phase Clinical Trials, Non-Communicable Diseases |
| Founded | 2016 |
| Employees | 1-10 |
| Socials |
Key Contacts at George Medicines
Gary Quashie
Senior Director, Business Development - Licensing & Alliance Management
Kevin Spivey
Director Of Clinical Operations
About George Medicines
George Medicines is a late-stage biopharmaceutical company addressing significant unmet need in the treatment of cardiometabolic diseases with innovative combinations of best-in-class existing treatments, designed for optimal efficacy and safety. Combining best-in-class molecules from existing medicines in novel low-dose formulations, George Medicines is developing innovative and proprietary treatments to be more efficacious, safer and accessible than currently available treatment options. These multi-mechanism, single-pill combinations offer the potential to bring significant improvements in clinical outcomes and therapy adherence in patients with cardiometabolic disorders, including hypertension and diabetes, each of which remain the leading causes of premature death and disability worldwide. The Company’s lead candidate, GMRx2, has completed a Phase III development program for the treatment of hypertension, including first-line therapy, and a global trial focused on the prevention of recurrent intracerebral hemorrhage (the most severe type of stroke) is underway. George Medicines is an independent spin-out company from The George Institute for Global Health, one of the world’s leading medical research institutes with a focus on addressing global health inequity. The Company is backed by George Health, the commercial arm of The George Institute, and Brandon Capital, Australia’s leading life sciences venture capital firm. For more information, please visit www.george-medicines.com.
George Medicines revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $2,500,000 |
| Total funding | $1,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
George Medicines has 5 employees across 4 departments.
Departments
Number of employees
Funding Data
Explore George Medicines's funding history, including investment rounds, total capital raised, and key backers.
George Medicines Tech Stack
Discover the technologies and tools that power George Medicines's digital infrastructure, from frameworks to analytics platforms.
Caching
JavaScript libraries
JavaScript libraries
CDN
Web servers
JavaScript frameworks
SEO
JavaScript libraries
Programming languages
Blogs
CDN
Analytics
United States
Netherlands
Spain
Australia
Frequently asked questions
4.8
40,000 users
